4th Quarter - Report

INVARIANT LLC for ELI LILLY AND COMPANY

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Support H.R. 1548, Pathway for Biosimilars Act, and similar proposals included in the House and Senate pharmaceutical health reform legislation; and monitor health reform legislation and oppose price control proposals (H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, the Patient Protection and Affordable Care Act).

LobbyistCovered position, as disclosed
JULIAN A HAYWOOD Legislative Assistant, Rep. Julian Dixon
HEATHER PODESTA Research Assistant, Congressional Budget Office
STACY STORDAHL Staff Assistant, Senator Donald Riegle, Jr.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), H.R. 3590 (111th), H.R. 3200 (111th), H.R. 3962 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.